Acceleron Pharma Inc


XLRN

Price

173


Change

0.06


High

NA


Low

NA


Avg Volume

2,101,942


PE Ratio

-46.63


52 Week High

189.99


52 Week Low

99.98



Profile

Acceleron Pharma, Inc. is a public American "clinical stage biopharmaceutical company" based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels. Acceleron has four drugs in clinical trials, and one in preclinical development.


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.